Literature DB >> 19098894

Induced pluripotent stem cells from a spinal muscular atrophy patient.

Allison D Ebert1, Junying Yu, Ferrill F Rose, Virginia B Mattis, Christian L Lorson, James A Thomson, Clive N Svendsen.   

Abstract

Spinal muscular atrophy is one of the most common inherited forms of neurological disease leading to infant mortality. Patients have selective loss of lower motor neurons resulting in muscle weakness, paralysis and often death. Although patient fibroblasts have been used extensively to study spinal muscular atrophy, motor neurons have a unique anatomy and physiology which may underlie their vulnerability to the disease process. Here we report the generation of induced pluripotent stem cells from skin fibroblast samples taken from a child with spinal muscular atrophy. These cells expanded robustly in culture, maintained the disease genotype and generated motor neurons that showed selective deficits compared to those derived from the child's unaffected mother. This is the first study to show that human induced pluripotent stem cells can be used to model the specific pathology seen in a genetically inherited disease. As such, it represents a promising resource to study disease mechanisms, screen new drug compounds and develop new therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19098894      PMCID: PMC2659408          DOI: 10.1038/nature07677

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  41 in total

Review 1.  Neuronal specification in the spinal cord: inductive signals and transcriptional codes.

Authors:  T M Jessell
Journal:  Nat Rev Genet       Date:  2000-10       Impact factor: 53.242

2.  Essential role for the SMN complex in the specificity of snRNP assembly.

Authors:  Livio Pellizzoni; Jeongsik Yong; Gideon Dreyfuss
Journal:  Science       Date:  2002-11-29       Impact factor: 47.728

3.  The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.

Authors:  U R Monani; M Sendtner; D D Coovert; D W Parsons; C Andreassi; T T Le; S Jablonka; B Schrank; W Rossoll; W Rossol; T W Prior; G E Morris; A H Burghes
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

Review 4.  Using human neural stem cells to model neurological disease.

Authors:  Rebekah J Jakel; Bernard L Schneider; Clive N Svendsen
Journal:  Nat Rev Genet       Date:  2004-02       Impact factor: 53.242

5.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

6.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

7.  CNS stem cells express a new class of intermediate filament protein.

Authors:  U Lendahl; L B Zimmerman; R D McKay
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

8.  International SMA consortium meeting. (26-28 June 1992, Bonn, Germany).

Authors:  T L Munsat; K E Davies
Journal:  Neuromuscul Disord       Date:  1992       Impact factor: 4.296

9.  Valproic acid increases SMN levels in spinal muscular atrophy patient cells.

Authors:  Charlotte J Sumner; Thanh N Huynh; Jennifer A Markowitz; J Stephen Perhac; Brenna Hill; Daniel D Coovert; Kristie Schussler; Xiaocun Chen; Jill Jarecki; Arthur H M Burghes; J Paul Taylor; Kenneth H Fischbeck
Journal:  Ann Neurol       Date:  2003-11       Impact factor: 10.422

10.  Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.

Authors:  L Brichta; Y Hofmann; E Hahnen; F A Siebzehnrubl; H Raschke; I Blumcke; I Y Eyupoglu; B Wirth
Journal:  Hum Mol Genet       Date:  2003-07-29       Impact factor: 6.150

View more
  611 in total

1.  Dedifferentiation rescues senescence of progeria cells but only while pluripotent.

Authors:  Laura J Niedernhofer; Joseph C Glorioso; Paul D Robbins
Journal:  Stem Cell Res Ther       Date:  2011-06-01       Impact factor: 6.832

Review 2.  Diseases in a dish: modeling human genetic disorders using induced pluripotent cells.

Authors:  Gustavo Tiscornia; Erica Lorenzo Vivas; Juan Carlos Izpisúa Belmonte
Journal:  Nat Med       Date:  2011-12       Impact factor: 53.440

3.  Human stem cells as a model of motoneuron development and diseases.

Authors:  Yan Liu; Su-Chun Zhang
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

Review 4.  Impact of induced pluripotent stem cells on the study of central nervous system disease.

Authors:  Paige E Cundiff; Stewart A Anderson
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

Review 5.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

Review 6.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

7.  Antisense oligonucleotides shed new light on the pathogenesis and treatment of spinal muscular atrophy.

Authors:  Jiing-Kuan Yee; Ren-Jang Lin
Journal:  Mol Ther       Date:  2012-01       Impact factor: 11.454

Review 8.  Stem cells as a potential therapy for epilepsy.

Authors:  Steven N Roper; Dennis A Steindler
Journal:  Exp Neurol       Date:  2012-01-13       Impact factor: 5.330

Review 9.  Induced pluripotent stem cells: the new patient?

Authors:  Milena Bellin; Maria C Marchetto; Fred H Gage; Christine L Mummery
Journal:  Nat Rev Mol Cell Biol       Date:  2012-10-04       Impact factor: 94.444

Review 10.  Stem cells in the nervous system.

Authors:  Angel R Maldonado-Soto; Derek H Oakley; Hynek Wichterle; Joel Stein; Fiona K Doetsch; Christopher E Henderson
Journal:  Am J Phys Med Rehabil       Date:  2014-11       Impact factor: 2.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.